ATE196688T1 - Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren - Google Patents

Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren

Info

Publication number
ATE196688T1
ATE196688T1 AT96919762T AT96919762T ATE196688T1 AT E196688 T1 ATE196688 T1 AT E196688T1 AT 96919762 T AT96919762 T AT 96919762T AT 96919762 T AT96919762 T AT 96919762T AT E196688 T1 ATE196688 T1 AT E196688T1
Authority
AT
Austria
Prior art keywords
tumour
cells
drug
sample
pct
Prior art date
Application number
AT96919762T
Other languages
English (en)
Inventor
Leif Hakansson
Annika Hakansson
Bertil Gustafsson
Original Assignee
Landstinget I Oestergoetland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Landstinget I Oestergoetland filed Critical Landstinget I Oestergoetland
Application granted granted Critical
Publication of ATE196688T1 publication Critical patent/ATE196688T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96919762T 1995-05-12 1996-05-10 Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren ATE196688T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501782A SE9501782D0 (sv) 1995-05-12 1995-05-12 Method of predicting the therapeutic response of a drug against a malignant tumour
PCT/EP1996/002007 WO1996035949A1 (en) 1995-05-12 1996-05-10 Method and kit for predicting the therapeutic response of a drug against a malignant tumour

Publications (1)

Publication Number Publication Date
ATE196688T1 true ATE196688T1 (de) 2000-10-15

Family

ID=20398299

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919762T ATE196688T1 (de) 1995-05-12 1996-05-10 Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren

Country Status (12)

Country Link
US (1) US6114128A (de)
EP (1) EP0824696B1 (de)
JP (1) JPH11504715A (de)
AT (1) ATE196688T1 (de)
CA (1) CA2215627A1 (de)
DE (1) DE69610496T2 (de)
DK (1) DK0824696T3 (de)
ES (1) ES2151665T3 (de)
GR (1) GR3034891T3 (de)
PT (1) PT824696E (de)
SE (1) SE9501782D0 (de)
WO (1) WO1996035949A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824467A (en) * 1997-02-25 1998-10-20 Celtrix Pharmaceuticals Methods for predicting drug response
US6087090A (en) * 1997-02-25 2000-07-11 Celtrix Pharmaceuticals, Inc. Methods for predicting drug response
US20030096237A1 (en) * 2000-08-28 2003-05-22 Ulrich Certa Determination of the ability of patients to respond to a tumor treatment
SE0402536D0 (sv) 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
RS54416B1 (sr) 2009-10-19 2016-04-28 Rostaquo S.P.A. Rostafuroksin za farmakogenomsko lečenje kardiovaskularnih stanja
US20130216557A1 (en) * 2010-08-14 2013-08-22 Biogen Idec Ma Inc. Ltbr blockade: methods for optimizing therapeutic responsiveness of patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
CA1296622C (en) * 1986-08-12 1992-03-03 Jeffrey E. Anderson Method and apparatus for automated assessment of the immunoregulatory status of the mononuclear leukocyte immune system

Also Published As

Publication number Publication date
CA2215627A1 (en) 1996-11-14
PT824696E (pt) 2001-03-30
JPH11504715A (ja) 1999-04-27
DE69610496D1 (de) 2000-11-02
US6114128A (en) 2000-09-05
DE69610496T2 (de) 2001-05-10
DK0824696T3 (da) 2001-01-02
EP0824696A1 (de) 1998-02-25
GR3034891T3 (en) 2001-02-28
WO1996035949A1 (en) 1996-11-14
SE9501782D0 (sv) 1995-05-12
EP0824696B1 (de) 2000-09-27
ES2151665T3 (es) 2001-01-01

Similar Documents

Publication Publication Date Title
Pinkus et al. Specific identification of intracellular immunoglobulin in paraffin sections of multiple myeloma and macroglobulinemia using an immunoperoxidase technique
Pickl et al. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes
EP0852004A2 (de) Gleichzeitige mehrfachanalyse klinischer proben
CA1270194A (en) Method for enhancing and/or accelerating immunoassay detection of human carcinoma tumor associated antigen in a pathology sample
ATE318147T1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
ATE443147T1 (de) Sphingosin-1-phosphat-lyase polypeptide, polynukleotide und modulierende mitteln, und verfahren zu deren verwendung
KR870700139A (ko) 인체의 비-소세포 폐암치료용 단클론의 항체 및 항원
CA1305928C (en) Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
Bentley et al. Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro
SE9500023L (sv) Sätt att detektera cancer
Saiki et al. In vitro induction of IgM secretion and switching to IgG production in human B leukemic cells with the help of T cells.
Logan et al. Use of Peyer's patch and lymph node fragment cultures to compare local immune responses to Morganella morganii
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
Bloom et al. In vitro methods in cell-mediated immunity: a progress report
ATE68600T1 (de) Satz und verfahren zur diagnose der iganephropathie.
Looi et al. Morphologic differences in the pattern of liver infiltration between systemic AL and AA amyloidosis
DE69610496D1 (de) Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren
Gopal et al. C-myc and c-myb expression in acute myelogenous leukemia
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
Befus et al. Mast cell differentiation and heterogeneity
US20060263373A1 (en) Utilization of an aminopeptidase inhibitor
ATE130100T1 (de) Verfahren zur immunologischen erkennung maligner tumore und kit zur durchführung dieses verfahrens.
PL322209A1 (en) Detection of antibody production
Zipf et al. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies
Keiser et al. The detection and identification of antibodies to saline extractable nuclear antigens by counterimmunoelectrophoresis

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee